Hemab Therapeutics Holdings, Inc. (COAG) — Institutional Holders, Q2 2026

56 institutional investment managers reported a COAG position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $1.3B. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

COAG 13F holders ranked 1–56 of 56

Institutional investors reporting a position in Hemab Therapeutics Holdings, Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
RA CAPITAL MANAGEMENT, L.P.#1 · 7,808,627 sh$286.8M—
Novo A/S#2 · 4,180,550 sh$153.6M—
FMR#3 · 3,697,837 sh$135.8M—
Capital International Investors#4 · 3,603,876 sh$132.4M—
Deep Track Capital#5 · 3,602,093 sh$132.3M—
Siren, L.L.C.#6 · 2,086,834 sh$76.6M—
Avoro Capital Advisors#7 · 1,925,150 sh$70.7M—
Bain Capital Life Sciences Investors#8 · 1,650,000 sh$60.6M—
JPMORGAN CHASE#9 · 1,152,420 sh$42.3M—
VANGUARD CAPITAL MANAGEMENT#10 · 780,758 sh$28.7M—
PRICE T ROWE ASSOCIATES#11 · 746,040 sh$27.4M—
DRIEHAUS CAPITAL MANAGEMENT#12 · 715,791 sh$26.3M—
Rock Springs Capital Management#13 · 575,432 sh$21.1M—
Bellevue Group AG#14 · 550,000 sh$20.2M—
CITADEL ADVISORS#15 · 523,450 sh$19.2M—
BlackRock#16 · 283,833 sh$10.4M—
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)#17 · 275,000 sh$10.1M—
ExodusPoint Capital Management#18 · 218,287 sh$8.0M—
GEODE CAPITAL MANAGEMENT#19 · 211,798 sh$7.8M—
BRAIDWELL#20 · 160,000 sh$5.9M—
MARSHALL WACE, LLP#21 · 154,674 sh$5.7M—
Woodline Partners#22 · 150,040 sh$5.5M—
Affinity Asset Advisors#23 · 138,030 sh$5.1M—
Ensign Peak Advisors#24 · 115,394 sh$4.2M—
VANGUARD FIDUCIARY#25 · 112,499 sh$4.1M—
CHARLES SCHWAB INVESTMENT MANAGEMENT#26 · 108,236 sh$4.0M—
AMERIPRISE FINANCIAL#27 · 81,928 sh$3.0M—
STATE STREET#28 · 76,900 sh$2.8M—
Burkehill Global Management#29 · 75,000 sh$2.8M—
abrdn plc#30 · 52,117 sh$1.9M—
Opaleye Management#31 · 47,652 sh$1.8M—
UBS Group AG#32 · 47,351 sh$1.7M—
Parkman Healthcare Partners#33 · 45,000 sh$1.7M—
NORTHERN#34 · 40,487 sh$1.5M—
Ghisallo Capital Management#35 · 40,000 sh$1.5M—
TD ASSET MANAGEMENT#36 · 33,098 sh$1.2M—
SEVEN GRAND MANAGERS#37 · 30,000 sh$1.1M—
SOROS FUND MANAGEMENT#38 · 25,000 sh$918.3K—
MANUFACTURERS LIFE INSURANCE COMPANY, THE#39 · 18,720 sh$687.6K—
GSA CAPITAL PARTNERS LLP#40 · 17,661 sh$649.0K—
XTX Topco Ltd#41 · 17,389 sh$638.7K—
LANDSCAPE CAPITAL MANAGEMENT, L.L.C.#42 · 13,183 sh$484.2K—
Hudson Bay Capital Management#43 · 12,202 sh$448.2K—
Schonfeld Strategic Advisors#44 · 10,813 sh$397.2K—
Weiss Asset Management#45 · 10,000 sh$367.3K—
VANGUARD PORTFOLIO MANAGEMENT#46 · 8,169 sh$300.0K—
Vanguard Global Advisers#47 · 7,616 sh$279.7K—
Squarepoint Ops#48 · 6,252 sh$229.6K—
TWO SIGMA INVESTMENTS#49 · 5,680 sh$208.6K—
MORGAN STANLEY#50 · 4,078 sh$149.8K—
China Universal Asset Management , Ltd.#51 · 3,600 sh$132.2K—
CITIGROUP#52 · 2,095 sh$76.9K—
BARCLAYS PLC#53 · 1,011 sh$37.1K—
ROYAL BANK OF CANADA#54 · 248 sh$9.0K—
JONES FINANCIAL COMPANIES LLLP#55 · 3 sh$97.00—
Tower Research Capital (TRC)#56 · 1 sh$37.00—

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for the prior quarter without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.